ES2123910T3 - Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol. - Google Patents

Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.

Info

Publication number
ES2123910T3
ES2123910T3 ES95301864T ES95301864T ES2123910T3 ES 2123910 T3 ES2123910 T3 ES 2123910T3 ES 95301864 T ES95301864 T ES 95301864T ES 95301864 T ES95301864 T ES 95301864T ES 2123910 T3 ES2123910 T3 ES 2123910T3
Authority
ES
Spain
Prior art keywords
alpha
hydroxiacides
amphoteral
salts
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95301864T
Other languages
English (en)
Inventor
Prakash Parab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2123910T3 publication Critical patent/ES2123910T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICIONES PARA REFORZAR LA PERMEABILIDAD Y RETENCION DE LA PIEL DE ACIDOS ALFA-HIDROXI PARA EL TRATAMIENTO DE DESORDENES DERMATOLOGICOS, Y QUE CONTIENEN UNA SAL ANFOTERICA DE ALFAHIDROXI, COMO ACIDO LACTICO, GLICOLICO, CITRICO, TARTARICO O MALICO Y UNA AMINOACIDO, DIEPEPTIDO, POLIPEPTIDO O PROTEINAS, EN UN PORTADOR DERMATOLOGICAMENTE ACEPTABLE QUE CONTIENE DEL 0,5 AL 8% DE GLICEROL MONOCAPRILADO, O DE 0 AL 80% DE PETROLATO Y DEL 0 AL 30% DE ISOPROPIL MIRISTATO, SIENDO EL PH DE LA COMPOSICION DE ALREDEDOR DE 3 A 9, Y UN METODO PARA UTILIZAR DICHA COMPOSICION.
ES95301864T 1994-03-22 1995-03-21 Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol. Expired - Lifetime ES2123910T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/215,984 US5420106A (en) 1994-03-22 1994-03-22 Method and composition having enhanced alpha-hydroxy acid skin permeation and retention

Publications (1)

Publication Number Publication Date
ES2123910T3 true ES2123910T3 (es) 1999-01-16

Family

ID=22805189

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95301864T Expired - Lifetime ES2123910T3 (es) 1994-03-22 1995-03-21 Composiciones que contienen sales anfoteras de alfa-hidroxiacidos y monocaprilato de glicerol.

Country Status (9)

Country Link
US (1) US5420106A (es)
EP (1) EP0673648B1 (es)
JP (1) JPH07258076A (es)
AU (1) AU690957B2 (es)
CA (1) CA2142940A1 (es)
DE (1) DE69506154T2 (es)
DK (1) DK0673648T3 (es)
ES (1) ES2123910T3 (es)
NZ (1) NZ270728A (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222818A1 (es) * 2003-07-25 2005-02-01 Luis Ucelay Sanz Emulsion de acido lactico.

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5505948A (en) * 1993-06-01 1996-04-09 Dermatology Home Products, Inc. Home skin peel composition for producing healthy and attractive skin
IL109012A (en) * 1994-03-17 1998-09-24 Fischer Pharma Ltd Skin whitening composition comprising glycyrrhyza glabra and hydroxy acids
DE4444237C2 (de) * 1994-12-13 2000-08-24 Beiersdorf Ag Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne
FR2729855A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
EP0810852A1 (en) * 1995-02-22 1997-12-10 Bausch & Lomb Incorporated Skin care composition
US5616617A (en) * 1995-11-27 1997-04-01 Van Moerkerken; Arthur Face pimples prevention method and compositions
GB9524575D0 (en) * 1995-12-01 1996-01-31 Unilever Plc Thickener for cosmetic composition
ES2110921B1 (es) * 1996-08-08 1998-10-01 Ternum S C C L Composicion anti-psoriasica y procedimiento para la preparacion de la misma.
FR2756489A1 (fr) * 1996-12-02 1998-06-05 Eynard Michele Compositions destinees au traitement des hyperkeratoses
FR2759295B1 (fr) * 1997-02-11 1999-04-16 Serobiologiques Lab Sa Composition active contre les effets du froid et produit cosmetique comportant une telle composition
US6143309A (en) 1998-03-12 2000-11-07 Archimica (Florida), Inc. Delivery of hydroxy carboxylic acids
AUPP583198A0 (en) * 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
AU3996799A (en) * 1999-05-18 2000-12-05 Klein, Marvin E. Alpha amino acid composition and method for the treatment of skin
US6353029B1 (en) * 2000-08-24 2002-03-05 Bristol-Myers Squibb Company Storage stable tretinoin and 4-hydroxyanisole containing topical composition
FR2816837A1 (fr) * 2000-11-17 2002-05-24 Oreal Utilisation d'au moins un derive amino sulfonique dans une composition destinee a favoriser la desquamation de la peau
AU2002314847A1 (en) 2001-05-31 2002-12-09 Upsher-Smith Laboratories, Inc. Dermatological compositions and methods comprising alpha-hydroxy acids or derivatives
DE10150727A1 (de) * 2001-10-13 2003-04-17 Cognis Deutschland Gmbh Kosmetische und/oder pharmazeutische Zubereitungen
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
DE60312160T2 (de) 2002-06-10 2007-10-31 Euro-Celtique S.A. Entsorgungssysteme für transdermale abgabevorrichtungen zur verhinderung des missbrauchs von darin enthaltenen wirkstoffen
EP1530469B1 (en) * 2002-08-20 2009-02-25 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and free-base form of an antagonist
US20070053848A1 (en) * 2003-08-26 2007-03-08 Stockel Richard F Antimicrobial materials for dental care applications
US20080020028A1 (en) * 2003-08-20 2008-01-24 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
US20070086977A1 (en) * 2003-12-22 2007-04-19 Stockel Richard F Method of treating dermatological conditions
US20050136024A1 (en) * 2003-12-22 2005-06-23 Stockel Richard F. Dermatological compositions
JP2007332047A (ja) * 2006-06-13 2007-12-27 Ogawa & Co Ltd 外用化粧料
JP2007332046A (ja) * 2006-06-13 2007-12-27 Ogawa & Co Ltd ヘアシャンプー
CN101646416B (zh) * 2007-03-20 2011-08-17 株式会社资生堂 皮肤外用组合物
US8440245B2 (en) 2009-03-26 2013-05-14 Abbott Laboratories Methods for making nutritional compositions comprising curcuminoids
US20100331412A1 (en) * 2009-03-30 2010-12-30 Patricia Lawler Kenet Two container skin care product
US20110152384A1 (en) * 2009-12-17 2011-06-23 Gunn Euen T Mild leave-on skin care compositions
JP5631837B2 (ja) * 2010-10-18 2014-11-26 株式会社ヤクルト本社 皮膚中濃度増加剤
DE102011056142A1 (de) * 2011-12-07 2013-06-13 Manfred Rüdinger Metabolisierbare Salze und deren Verwendung in Diagnostik und Therapie
CN108136026A (zh) * 2015-06-19 2018-06-08 全球健康方案有限责任公司 包含阳离子杀生物剂的基于凡士林的组合物
FR3086172B1 (fr) * 2018-09-26 2021-01-29 Gallinee Formulation cosmetique
EP3965724A4 (en) * 2019-05-06 2023-05-17 Spinart, LLC FORMULATIONS AND PROCESSES FOR THE MANUFACTURE OF STABLE COSMETIC COMPOSITIONS
US20200405609A1 (en) * 2019-06-26 2020-12-31 Johnson & Johnson Consumer Inc. Topical compositions containing n-acyl dipeptide derivatives and glycolic acid
CN118217177A (zh) * 2019-08-21 2024-06-21 株式会社Lg生活健康 包含共晶混合物的化妆料组合物
FR3130564B1 (fr) * 2021-12-21 2024-07-12 Oreal Composition comprenant une argile non modifiée, un sel de magnésium, un alphahydroxyacide et de l’eau.
CN116831956A (zh) * 2023-07-03 2023-10-03 杭州泽芙雪化妆品有限公司 一种可用于缓解皮肤干痒的保湿乳及其制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879537A (en) * 1973-09-04 1975-04-22 Scott Eugene J Van Treatment of ichthyosiform dermatoses
US4363815A (en) * 1975-07-23 1982-12-14 Yu Ruey J Alpha hydroxyacids, alpha ketoacids and their use in treating skin conditions
US4021572A (en) * 1975-07-23 1977-05-03 Scott Eugene J Van Prophylactic and therapeutic treatment of acne vulgaris utilizing lactamides and quaternary ammonium lactates
JPS6112621A (ja) * 1984-06-27 1986-01-21 Lion Corp パツプ剤
DE3511753A1 (de) * 1985-03-30 1986-10-02 Bayer Ag, 5090 Leverkusen Verwendung von efomycinen als wachstumsfoerderer, efomycine und ihre herstellung
US4732892A (en) * 1985-07-12 1988-03-22 American Home Products Corporation L-α-amino acids as transdermal penetration enhancers
AU618517B2 (en) * 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5091171B2 (en) * 1986-12-23 1997-07-15 Tristrata Inc Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
JPH0720866B2 (ja) * 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
FI903483A7 (fi) * 1989-07-13 1991-01-14 Bristol Myers Squibb Co Tretinoiinia sisältäviä stabiileja emulsiovoideformuloita
FI904753A7 (fi) * 1989-10-02 1991-04-03 Bristol Myers Squibb Co Parantuneen pysyvyyden omaavia emulgoituja tretinoiinivoidekoostumuksia
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
US5254343A (en) * 1991-03-19 1993-10-19 Bristol-Myers Squibb Company Reduction of cutaneous atrophy
TW218849B (es) * 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5306729A (en) * 1992-02-25 1994-04-26 Joslin Diabetes Center Method for effecting vasodilation with monoglycerides
CA2143515A1 (en) * 1994-03-22 1995-09-23 Prakash Parab Method for enhancing the rate of skin permeation of lactic acid through use of the l-enantiomer

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2222818A1 (es) * 2003-07-25 2005-02-01 Luis Ucelay Sanz Emulsion de acido lactico.
ES2222818B1 (es) * 2003-07-25 2007-03-01 Luis Ucelay Sanz Emulsion de acido lactico.

Also Published As

Publication number Publication date
EP0673648B1 (en) 1998-11-25
DE69506154D1 (de) 1999-01-07
JPH07258076A (ja) 1995-10-09
NZ270728A (en) 1997-10-24
CA2142940A1 (en) 1995-09-23
DE69506154T2 (de) 1999-05-06
DK0673648T3 (da) 1999-08-09
EP0673648A1 (en) 1995-09-27
US5420106A (en) 1995-05-30
HK1004473A1 (en) 1998-11-27
AU1497595A (en) 1995-09-28
AU690957B2 (en) 1998-05-07

Similar Documents

Publication Publication Date Title
AR042345A2 (es) Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma
ES2168334T3 (es) Composicion para el tratamiento de la piel.
DE69525545D1 (de) Wirkstoff zur erhöhung der produktion und der zucht von tieren in der geflügelindustrie
DE59306544D1 (de) Verwendungen von alpha-Hydroxyfettsäuren
YU99092A (sh) Organske soli n,n'-diacetilcistina i postupak za njihovo dobijanje
DE59305359D1 (de) Desodorierende kosmetische zubereitungen mit einem gehalt an di- oder triglycerinestern
MX9702272A (es) Inhibicion del crecimiento del cabello.
IL106248A (en) Adhesive compositions and method of bonding biological tissue to a substance
DE69317433D1 (de) Ungesättigte aliphatische dicarbonsäuren
DE69508192D1 (de) Wasserlösliches nimesulid-salz, sowie dessen verwendung zur behandlung von entzündungen
IT8320064A0 (it) Inibitori dell'enzima che trasforma l'angiotensina, costituiti da acidi amminoalchilfosfinici e da acidi amminofosfinici sostituiti simili.
DE69010162D1 (de) Zusammensetzung zur Behandlung von Entzündung.
PT93959A (pt) Processo para a preparacao de derivados de sacarina uteis como inibidores proteoliticos de enzima
NO843002L (no) Vandig loesning inneholdende en lipid-loeselig farmasoeytisk substans
BG103096A (en) Thrombin inhibitors
MY104412A (en) Acne treatment.
SE9303691D0 (sv) New beverage
FI940375A0 (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
ES2058599T3 (es) Procedimiento para mejorar la eficacia de las toxinas de insectos.
ES2053988T3 (es) Un metodo para la produccion de una composicion eficaz para traqueobroncodilatacion.
AR003418A1 (es) Composición farmacéutica con actividad antiepiléptica que contiene ácido r(-)-n- (4,4-di(3-metiltien-2-il) but-3-enil)-nipecótico o sus sales y el procedimiento para su preparación.
ATE108658T1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
SE9801090D0 (sv) New medium and process
ATE178206T1 (de) Verfahren zur vorbeugung und behandlung von durch chemotherapie ausgelöster alopezie
GR1002665B (el) Μεθοδος για την περιποιηση φυτων.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 673648

Country of ref document: ES